User login
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Article Type
Changed
Thu, 01/10/2019 - 11:57
Display Headline
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Article PDF
Issue
Cutis - 70(6)
Publications
Topics
Page Number
335-339
Sections
Article PDF
Article PDF
Issue
Cutis - 70(6)
Issue
Cutis - 70(6)
Page Number
335-339
Page Number
335-339
Publications
Publications
Topics
Article Type
Display Headline
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Display Headline
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document